These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 20445192
1. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. Zimmerhackl LB, Hofer J, Cortina G, Mark W, Würzner R, Jungraithmayr TC, Khursigara G, Kliche KO, Radauer W. N Engl J Med; 2010 May 06; 362(18):1746-8. PubMed ID: 20445192 [No Abstract] [Full Text] [Related]
2. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases. Nester CM, Brophy PD. Curr Opin Pediatr; 2013 Apr 06; 25(2):225-31. PubMed ID: 23486421 [Abstract] [Full Text] [Related]
3. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T. Am J Kidney Dis; 2010 Apr 06; 55(4):708-11. PubMed ID: 19854549 [Abstract] [Full Text] [Related]
4. Eculizumab for atypical hemolytic-uremic syndrome. Nürnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M. N Engl J Med; 2009 Jan 29; 360(5):542-4. PubMed ID: 19179328 [No Abstract] [Full Text] [Related]
5. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H. Riedl M, Rosales A, Zimmerhackl LB, Jungraithmayr T. Pediatr Transplant; 2011 May 29; 15(3):225-8. PubMed ID: 21492349 [No Abstract] [Full Text] [Related]
6. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM. Am J Kidney Dis; 2017 Dec 29; 70(6):770-777. PubMed ID: 28821363 [Abstract] [Full Text] [Related]
7. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Châtelet V, Lobbedez T, Frémeaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B. Transplant Proc; 2010 Dec 29; 42(10):4353-5. PubMed ID: 21168697 [Abstract] [Full Text] [Related]
12. Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. Zlamy M, Hofer J, Elias J, Vogel U, Frosch M, Jungraithmayr T, Zimmerhackl LB, Prelog M. Pediatr Transplant; 2012 Sep 29; 16(6):E246-50. PubMed ID: 21967634 [Abstract] [Full Text] [Related]